Paper8395751
Use of octreotide acetate for control of symptoms in patients with islet cell tumors.
Maton PN. World J Surg, 1993. Cited by 36 papers, by iCite.
Cite this record
ConductScience Library. Use of octreotide acetate for control of symptoms in patients with islet cell tumors. Papers, record 8395751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8395751
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenoma, Islet Cell | Major topic |
| Octreotide | Major topic |
| Pancreatic Neoplasms | Major topic |
| Humans |
Source PubMed
References55
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 2575602 | Recent advances in the management of gastric acid hypersecretion in patients with Zollinger-Ellison syndrome. | Gastroenterol Clin North Am | 1989 | https://conductscience.org/library/papers/2575602 | PubMed |
| 2 | 90860 | Suppression of pancreatic endocrine tumour secretion by long-acting somatostatin analogue. | Lancet | 1979 | https://conductscience.org/library/papers/90860 | PubMed |
| 3 | 2872593 | Cushing's syndrome in patients with the Zollinger-Ellison syndrome. | N Engl J Med | 1986 | https://conductscience.org/library/papers/2872593 | PubMed |
| 4 | 2861106 | Effect of long acting somatostatin-analogue, SMS 201 995, on gut hormone secretion in normal subjects. | Experientia | 1985 | https://conductscience.org/library/papers/2861106 | PubMed |
| 5 | 6311653 | Functional and morphologic characterization of human insulinomas. | Diabetes | 1983 | https://conductscience.org/library/papers/6311653 | PubMed |
| 6 | 6120969 | Effect of somatostatin on gastrin, insulin and glucagon secretion in two patients with Zollinger-Ellison syndrome. | J Endocrinol Invest | 1981 | https://conductscience.org/library/papers/6120969 | PubMed |
| 7 | 173625 | Proceedings: Investigation and treatment of a recurrent vipoma. | Gut | 1975 | https://conductscience.org/library/papers/173625 | PubMed |
| 8 | 2565913 | Long term effects of continuous subcutaneous infusion of the somatostatin analog octreotide in the treatment of acromegaly. | J Clin Endocrinol Metab | 1989 | https://conductscience.org/library/papers/2565913 | PubMed |
| 9 | 4594711 | Somatostatin: hypothalamic inhibitor of the endocrine pancreas. | Science | 1974 | https://conductscience.org/library/papers/4594711 | PubMed |
| 10 | 6128648 | SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action. | Life Sci | 1982 | https://conductscience.org/library/papers/6128648 | PubMed |
| 11 | 221293 | Responses of patients with insulinomas to stimulators and inhibitors of insulin release that have been linked with cyclic adenosine monophosphate. | Diabetes | 1979 | https://conductscience.org/library/papers/221293 | PubMed |
| 12 | 1968417 | Effect of the somatostatin analogue SMS 201-995 on faecal fat excretion in acromegaly. | Horm Metab Res | 1990 | https://conductscience.org/library/papers/1968417 | PubMed |
| 13 | 6114963 | Use of somatostatin and somatostatin analogs in a patient with a glucagonoma. | J Clin Endocrinol Metab | 1981 | https://conductscience.org/library/papers/6114963 | PubMed |
| 14 | 2860768 | A somatostatin analogue inhibits chondrosarcoma and insulinoma tumour growth. | Acta Endocrinol (Copenh) | 1985 | https://conductscience.org/library/papers/2860768 | PubMed |
| 15 | 2229321 | Gastrointestinal side-effects of octreotide during long-term treatment of acromegaly. | J Clin Endocrinol Metab | 1990 | https://conductscience.org/library/papers/2229321 | PubMed |
| 16 | 4139406 | Inhibition of gastrin and gastric-acid secretion by growth-hormone release-inhibiting hormone. | Lancet | 1974 | https://conductscience.org/library/papers/4139406 | PubMed |
| 17 | 2543178 | The effect of the long-acting somatostatin analogue SMS 201-995 on ACTH secretion in Nelson's syndrome and Cushing's disease. | Acta Endocrinol (Copenh) | 1989 | https://conductscience.org/library/papers/2543178 | PubMed |
| 18 | 2906126 | A case of somatostatinoma: responses to food and SMS 201-995 administration. | Pancreas | 1988 | https://conductscience.org/library/papers/2906126 | PubMed |
| 19 | 2568300 | Pharmacological effect of somatostatin on bile secretion in man. | Digestion | 1989 | https://conductscience.org/library/papers/2568300 | PubMed |
| 20 | 2559036 | The use of the long-acting somatostatin analogue, octreotide acetate, in patients with islet cell tumors. | Gastroenterol Clin North Am | 1989 | https://conductscience.org/library/papers/2559036 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 36 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 35838801 | Complete remission of recurrent multiple insulin-producing neuroendocrine tumors of the pancreas with somatostatin analogs: a case report and literature review. | Discov Oncol | 2022 | https://conductscience.org/library/papers/35838801 | PubMed |
| 34093445 | Role of Somatostatin Receptor in Pancreatic Neuroendocrine Tumor Development, Diagnosis, and Therapy. | Front Endocrinol (Lausanne) | 2021 | https://conductscience.org/library/papers/34093445 | PubMed |
| 32121432 | Somatostatin Analogs in Clinical Practice: a Review. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32121432 | PubMed |
| 25741154 | Appropriateness of systemic treatments in unresectable metastatic well-differentiated pancreatic neuroendocrine tumors. | World J Gastroenterol | 2015 | https://conductscience.org/library/papers/25741154 | PubMed |
| 24312683 | Advances in the Treatment of Pancreatic Neuroendocrine Tumors (pNETs). | Gastrointest Cancer Res | 2013 | https://conductscience.org/library/papers/24312683 | PubMed |
| 22089253 | Abdominal mass, anemia, diabetes mellitus, and necrolytic migratory erythema. | Dig Dis Sci | 2012 | https://conductscience.org/library/papers/22089253 | PubMed |
| 20146582 | Insulinoma: pathophysiology, localization and management. | Future Oncol | 2010 | https://conductscience.org/library/papers/20146582 | PubMed |
| 19693706 | PPI-delayed diagnosis of gastrinoma: oncologic victim of pharmacologic success. | Pathol Oncol Res | 2010 | https://conductscience.org/library/papers/19693706 | PubMed |
| 8977344 | Treatment of the carcinoid syndrome with the longacting somatostatin analogue lanreotide: a prospective study in 39 patients. | Gut | 1996 | https://conductscience.org/library/papers/8977344 | PubMed |
| 8943970 | Mechanisms of bombesin on growth of gastrinoma (PT) in vivo. | Dig Dis Sci | 1996 | https://conductscience.org/library/papers/8943970 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| GHRH | 2691 | PubTator's text mining | https://conductscience.org/library/genes/2691 | NCBI Gene |
| SST | 6750 | PubTator's text mining | https://conductscience.org/library/genes/6750 | NCBI Gene |
| VIP | 7432 | PubTator's text mining | https://conductscience.org/library/genes/7432 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8395751
GET https://conductscience.org/api/papers/v1/8395751/references?page=2